Showing 241 - 260 results of 224,865 for search '(( a d decrease ) OR ( 10 ((((nm decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.75s Refine Results
  1. 241
  2. 242
  3. 243
  4. 244
  5. 245
  6. 246
  7. 247
  8. 248
  9. 249
  10. 250
  11. 251

    Decreased frequency of sEPSCs in <i>Dyt1</i> heterozygous KO mice. by Fumiaki Yokoi (170876)

    Published 2015
    “…<p>(A) Representative traces for sEPSCs. <i>Dyt1</i> heterozygous KO mice had a significantly decreased frequency of sEPSCs (B), but no change in either the amplitude (C), or rise (D) and decay (E) times of these events. …”
  12. 252
  13. 253
  14. 254

    Decreased Patrolling Efficiency and Decreased ConA Hepatitis Severity in CXCR6-Deficient Mice by Frederic Geissmann (75)

    Published 2013
    “…Utilizing the lymphocyte velocity data (left panel) and assuming that a CD1d-reactive T cell can contact only one hepatocyte at a time, we calculated that each CD1d-reactive T cell can visit 0.58 hepatocytes/min in the <i>cxcr6<sup>gfp/+</sup></i> mice, and 0.64 hepatocytes/min in the CXCR6-deficient mice. …”
  15. 255

    Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

    Published 2019
    “…<p>(A-D) Double staining of untreated 5xFAD mice brain sections with the 4g8 and SMI31 antibodies revealed that the areas with higher incidence of DNs display the greater total Aβ halo around the plaques (AmyloGlo+). …”
  16. 256

    Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs. by Jingping Ge (636557)

    Published 2015
    “…The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”
  17. 257

    Wnt5a expressing tumors demonstrate a decrease in markers of the basal tumor subtype. by Stephanie L. Easter (662168)

    Published 2014
    “…MMTV-Wnt1;MMTV-Wnt5a tumors demonstrated a significant decrease in K6-expressing cells as measured by T-test (* = p<0.05).…”
  18. 258
  19. 259

    Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints. by Aeron M. Small (9617751)

    Published 2020
    “…<p>Odds ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”
  20. 260